OLBAS Drops, 50 ml

Instructions for use for OLBAS Drops, 50 ml

Directions for use of the article Olbas drops: Olbas drops are traditionally used for the treatment of colds such as coughs, colds, hoarseness. They can also be taken for mild cramp-like complaints in the gastrointestinal tract and are suitable for external use for mild headaches and muscle aches after overexertion or incorrect strain. Please read the package leaflet before use and consult your doctor or pharmacist to avoid risks and side effects. Dosage and directions for use: - Adolescents aged 12 years and over and adults should take 3 drops of Olbas drops 3 times a day, spread throughout the day. - Adults can take 3 drops 3 times a day for mild cramp-like gastrointestinal complaints. - For inhalation for colds, 2-4 drops of Olbas drops can be added to hot water and the vapours inhaled. This application can be repeated up to 3 times a day. - For mild headaches, 2-3 drops of Olbas drops can be applied to the forehead, temples or neck. Take care that the drops do not get into the eyes. - For muscle pain, 2-3 drops of Olbas drops can be applied to the affected muscle areas and gently massaged in. Information on contraindications and side effects: Olbas drops should not be used in cases of hypersensitivity to the ingredients, bronchial hypersensitivity, damaged skin, children with seizure disorders, gall, liver or kidney disorders and stomach disorders. It is not recommended for use during pregnancy and breastfeeding. Side effects such as heartburn, nausea, vomiting, blurred vision, skin changes or headaches may occur. Please follow the prescribed dosage. Other important information: - Olbas drops should be kept out of the reach of children. - After opening the package, the drops should be used within 12 months. - Be aware of possible interactions with other medicines. - Avoid contact with eyes, mucous membranes and open skin areas. Olbas drops are available in the commercial form of SALUS PHARMA . Please visit www.duopharm.de for more information. Please note that this summary is based on the information in the package leaflet and does not contain repeated information.